Artificially Sweetened Beverages and Alzheimer Risk

Artificially sweetened beverages (with different kinds of sweeteners) could be responsible for increased cerebrovascular risk and close to a 3-fold increase in dementia risk due to Alzheimer’s disease.

Bebidas azucaradas y con edulcorante asociadas a eventos cardiovasculares y mortalidad

Both sweet and artificially sweetened drinks have been associated with cardiometabolic, cerebrovascular and dementia risk. This study prospectively evaluated sweet and sweetened beverage consumption in relation to the events above mentioned in the Framingham community. 

2888 participants over 45 years old were studied to assess the incidence of stroke and 1484 participants over 60 were studied to assess the incidence of dementia. 


Lea también: Bebidas azucaradas y con edulcorante asociadas a eventos cardiovasculares y mortalidad.


The number of drinks was measured using different specific questionnaires bearing in mind both recent and cumulative consumption in the 10-year follow-up. 

After adjusting for age, sex, education (to analyze dementia) calory intake, diet quality, physical activity and tobacco consumption, it was observed that high recent consumption and high cumulative consumption both increased the risk of stroke, any dementia and Alzheimer’s disease. 

When comparing to 0 consumption (as reference) the risk with sweetened beverages was nearly 3 times higher for stroke (HR 2.96 CI 95%, 1.26 to 6.97) and Alzheimer’s (HR 2.89 CI 95%, 1.18 to 7.07). 


Read also: Primary Prevention Guidelines Published for the First Time: Are They Useful for All Patients?


Beverages with natural sugar were not associated to stroke or dementia. 

All this information is contradicting and there are other studies with literally opposite results. The problem is randomizing and, even though multiple adjustments are made, there might be variables out of control. On example could be that the populations at higher risk of events (obesity and diabetes) consume more artificially sweetened beverages and therefore beverages wouldn’t be the cause behind events, but the baseline risk of this population. 

2020-01-14-pase2019

Original Title: Sugar- and Artificially Sweetened Beverages and the Risks of Incident Stroke and Dementia. A Prospective Cohort Study.

Reference: Matthew P. Pase et al. Stroke. 2017;48:1139-1146.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...